Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ I;+>@Cn(g<
u$ff %`E
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© }$@ EpM
_l=X?/
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© OpLUmn
y4Lh:;
1.Co-stimulators (or co-stimulating molecules) DT3koci(
y)mtSA8
2.NK-kB 1-}
M5]Y
BjV;/<bt
3.Immunoglobulin superfamily s7s@!~
T0"q,lrdxV
4.antigen-presenting cell (APC) |6 E
!wW
mO&zE;/[
5.death domain ]:.9:RmEV
X][=(l!;w7
6.CCR and CXCR ][B>`gC-
1ZO/R%[
7.Lectin (or mitogen) kerBy\^
2q ~y\fe
8.Clusters of differentiation, CD) Eg4_kp0Lq
wVkRrFJ
9.B7 family LTcZdQd$
TV~S#yg+H
10.Cytotoxic T lymphocyte, CTL) 4ZtsLMwLD
WT jy"p*
11.IL-15 and IL-15 receptor (IL-15R) 4rUOk"li
,D2nUk
12.MHC restriction G<Y}QhFU
9{8xMM-
13.Affinity-chromatography +^ `n- m
N1Dr'aw*
14.Cyctosprin A, CsA DVjwY_nG7
R
<;;Ph
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) !7Nz_d~n
\nU_UH
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© lH/7m;M
,M=s3D
8C
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 $Z<x r
,$Xhw
r
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ s
PvjJ r"s
dz1kQzOU*
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 ^J)0i_RS
T l8`3`e
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ]nq/yAF%
qm< mw"]
ÃâÒßѧרҵ£º 2b&Fu\2Dmv
V#X<Yt
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ WJy\{YAG
OJD!Ar8Q
Ïû»¯ÄÚ¿Æ£º e?+&2zMq
Y6m:d&p=}
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ P4fnBH4OQ
eu'S~c-l
ѪҺ²¡Ñ§×¨Òµ£º w9675D+
w%- S5#
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿